These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38325401)

  • 1. Placenta Invasion Anomaly without Placenta Previa in the First Trimester of Pregnancy and its Conservative Management: A Case Presentation.
    Jafarzade A
    Z Geburtshilfe Neonatol; 2024 Jun; 228(3):290-293. PubMed ID: 38325401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.
    Cui R; Li M; Lu J; Bai H; Zhang Z
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):298. PubMed ID: 29996794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study.
    Hu Q; Li C; Luo L; Li J; Zhang X; Chen S; Yang X
    BMC Pregnancy Childbirth; 2021 Aug; 21(1):568. PubMed ID: 34407784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conservative management of placenta previa accreta during cesarean section.
    Lam H; Pun TC; Lam PW
    Int J Gynaecol Obstet; 2004 Jul; 86(1):31-2. PubMed ID: 15207668
    [No Abstract]   [Full Text] [Related]  

  • 5. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placenta accreta spectrum disorders in the first trimester: a systematic review.
    Guzmán López JA; Gutiérrez Sánchez LÁ; Pinilla-Monsalve GD; Timor-Tritsch IE
    J Obstet Gynaecol; 2022 Aug; 42(6):1703-1710. PubMed ID: 35724241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta previa, placenta accreta, and vasa previa.
    Oyelese Y; Smulian JC
    Obstet Gynecol; 2006 Apr; 107(4):927-41. PubMed ID: 16582134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 47 cases of placenta accreta in the second and third trimesters].
    Zhang C; Liu XY; Fan GS; Yang JQ; Liu JT; Bian XM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):506-9. PubMed ID: 19080513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Placenta Accreta Spectrum.
    Berkley EM; Abuhamad A
    Clin Obstet Gynecol; 2018 Dec; 61(4):755-765. PubMed ID: 30339609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central placenta praevia accreta with focal bladder percretism. Conservative management.
    Leanza V; Verzì MG; Genovese F; Colaleo FM; Leanza G; Palumbo M
    Ann Ital Chir; 2021 May; 10():. PubMed ID: 33994388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of placenta previa-accreta by prophylactic uterine arteries ligation and uterine tamponade.
    Ferrazzani S; Guariglia L; Triunfo S; Caforio L; Caruso A
    Fetal Diagn Ther; 2009; 25(4):400-3. PubMed ID: 19786787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective First-Trimester Ultrasound Imaging of Low Implantation and Placenta Accreta Spectrum.
    Happe SK; Rac MWF; Moschos E; Wells CE; Dashe JS; McIntire DD; Twickler DM
    J Ultrasound Med; 2020 Oct; 39(10):1907-1915. PubMed ID: 32374433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal placentation: evidence-based diagnosis and management of placenta previa, placenta accreta, and vasa previa.
    Rao KP; Belogolovkin V; Yankowitz J; Spinnato JA
    Obstet Gynecol Surv; 2012 Aug; 67(8):503-19. PubMed ID: 22926275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal outcome after conservative management of abnormally invasive placenta.
    Su HW; Yi YC; Tseng JJ; Chen WC; Chen YF; Kung HF; Chou MM
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):353-357. PubMed ID: 28600047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic diagnosis of a non-previa placenta accreta.
    Jauniaux E; Toplis PJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Jan; 7(1):58-60. PubMed ID: 8932635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal placenta implantation. Integration between first- and third-trimester imaging in predicting the severity of Placenta Accreta Spectrum (PAS) disorders.
    D'Antonio F; Calagna G; Sara T; Gaspare C; Chiantera V; Calì G
    J Clin Ultrasound; 2023 Feb; 51(2):311-317. PubMed ID: 36468282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound.
    Chou MM; Ho ES; Lee YH
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):28-35. PubMed ID: 10776009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome.
    Calí G; Timor-Tritsch IE; Forlani F; Palacios-Jaraquemada J; Monteagudo A; Kaelin Agten A; Flacco ME; Khalil A; Buca D; Manzoli L; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):450-459. PubMed ID: 31788885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated first-trimester PAPP-A is a marker in high-risk pregnancies with an increased risk of placenta accreta in predicting adverse outcomes.
    Balkaş G; Çaglar T
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9955-9961. PubMed ID: 37916365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.